In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney, MD, MPH
Brigham and Women's Hospital, Division of Global Health Equity

Recent discussion topics

SIGN ON LETTER: Accelerate access to DR-TB drugs now

By Sharonann Lynch on 24 Feb 2015 0 Replies

[Please forward widely & excuse cross-posting] Call to action: Accelerate access to DR-TB drugs Médecins Sans Frontières (MSF), RESULTS UK, SWIFT, Treatment Action Campaign (TAC), Treatment Action Group (TAG) and others are calling on global health actors…

Whither the four month regimen?

By Dylan Tierney, MD, MPH on 19 Feb 2015 1 Recommendation 1 Reply

Lancet Infectious Disease just published an interesting opinion piece on what can be learned after the four recent negative trials on the use of fluoroquinolone containing regimens to shorten TB treatment. I have attached that piece to this post. The…

MSF letter: 1st EU Ministerial Meeting on TB and DR-TB

By Sharonann Lynch on 19 Feb 2015 0 Replies

Please find below a letter from MSF regarding the 1st EU Ministerial Meeting on TB and drug-resistant TB (DR-TB) taking place 30-31 March in Riga, Latvia, and the need for improving DR-TB management and R&D. You can download MSF's letter here:…

New community members

User Photo

Denis Gilbert UMUHIZI

Affiliated Organizations


Work Locations


User Photo

salman zahid

Affiliated Organizations


Work Locations

United Arab Emirates

User Photo

Anh Innes

Affiliated Organizations

FHI 360

Work Locations

Cambodia; China; Myanmar; Papua New Guinea; Thailand